| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.0077 | 1 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.00083 | 1 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |